Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2020 Nov 24;12:1758835920974212. doi: 10.1177/1758835920974212

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s), 2020

This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).

PMC Copyright notice

Figure 3. — High expression of PARPBP correlates with anthracycline resistance in breast cancer. (A) Representative images of immunohistochemical staining of PARPBP in chemo-resistant and non-resistant tumors are shown. Scale bars, 50 μm. (B) Expression of PARPBP in chemoresistant tumors were significantly higher than that in non-resistant breast tumors. (C) PARPBP/231 and Vector/231 cells were treated with various concentrations of EPI for 48 h. (D) PARPBP/BT549 and Vector/BT549 cells were treated with various concentrations of EPI for 48 h. *p < 0.05, **p < 0.01.

EPI, epirubicin; PARBP, PARP1 binding protein.